We analyzed the BCL-2, BCL-2 S70, and MCL-1 protein levels in a cohort of 66 pediatric AML by RPPA analysis (Aveic et al., 2015), and we subdivided the patients by BCL-2 protein expression quartiles. The gene discussed is MCL1; the disease is acute myeloid leukemia.